PHARMACEUTICAL CO-CRYSTAL OF CELECOXIB-NICOTINAMIDE

(19)

(11)

EP 1 608 339 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	25.04.2012 Bulletin 2012/17

(45)	Mention of the grant of the patent:
	21.03.2012 Bulletin 2012/12

(21)	Application number: 03754445.9

(22)	Date of filing: 04.09.2003

(51)

International Patent Classification (IPC):

A61K 31/415^(2006.01)

A61K 31/455^(2006.01)

(86)	International application number:
	PCT/US2003/027772

(87)	International publication number:
	WO 2004/078161 (16.09.2004 Gazette 2004/38)

(54)	PHARMACEUTICAL CO-CRYSTAL OF CELECOXIB-NICOTINAMIDE PHARMAZEUTISCHE MISCHKRISTALLE VON CELECOXIB-NICOTINAMID COMPOSITIONS CO-CRISTALLINES DE CELECOXIB-NICOTINAMIDE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

28.02.2003 US 451213 P
03.03.2003 US 378956
18.04.2003 US 463962 P
11.07.2003 US 487064 P

(43)	Date of publication of application:
	28.12.2005 Bulletin 2005/52

(73)	Proprietors:
	McNEIL-PPC, Inc. Skillman, NJ 08558 (US) UNIVERSITY OF SOUTH FLORIDA Tampa, FL 33620-7900 (US) THE REGENTS OF THE UNIVERSITY OF MICHIGAN Ann Arbor, Michigan 48109-1280 (US)

(72)	Inventors:
	ALMARSSON, Örn Shrewsbury, MA 01545 (US) BOURGHOL HICKEY, Magali Medford, MA 02155 (US) PETERSON, Matthew Framingham, MA 01701 (US) ZAWOROTKO, Michael, J. Tampa, FL 3362 (US) MOULTON, Brian Providence, RI 02912 (US) RODRIGUEZ-HORNEDO, Nair Ann Arbor, MI 48103 (US)

(74)	Representative: Cole, Paul Gilbert et al
	Lucas & Co., 135 Westhall Road Warlingham, Surrey CR6 9HJ Warlingham, Surrey CR6 9HJ (GB)

(56)

References cited: :

WO-A-01/42222
WO-A-03/033462

WO-A-01/51919
WO-A-03/074474

WEISSBUCH I ET AL: "Understanding and control of nucleation, growth, habit, dissolution and structure of two- and three-dimensional crystals using 'tailor-made' auxiliaries" 1995, ACTA CRYSTALLOGRAPHICA. SECTION B, STRUCTURAL SCIENCE, MUNKSGAARD, COPENHAGEN, DK, PAGE(S) 115-148 , XP002960386 ISSN: 0108-7681 the whole document abstract page 145, column 2, paragraph 2


	Remarks:
	The file contains technical information submitted after the application was filed and not included in this specification

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).